Argininosuccinate Synthase 1 Suppresses Tumor Progression Through Activation of PERK/eIF2α/ATF4/CHOP Axis in Hepatocellular Carcinoma

Sanghwa Kim(Institut Pasteur Korea), Haengran Seo(Institut Pasteur)

Research Square

December 14, 2020

10.21203/rs.3.rs-125320/v1

Cited by 2

Related Papers

Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma

|Journal of Experimental & Clinical Cancer Research|2021|68